Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Outcomes of adolescent and young adult patients with AML treated on adult versus pediatric protocols

Ira Kraft, Venkata Preetam Sandeep Kaduluri, Kelsey Pandrangi, John Molina, Jonathan Webster, B. Douglas Smith, Alex Ambinder, Heather Symons

Blood (2025) 146 (Supplement 1): 2832.

https://doi.org/10.1182/blood-2025-2832

Published: 2025

Journal Articles

Infection risk factors and burden in patients treated with T-cell engaging bispecific antibodies for relapsed B-cell lymphoma and multiple myeloma

Blood (2025) 146 (Supplement 1): 2814.

https://doi.org/10.1182/blood-2025-2814

Published: 2025

Journal Articles

Clinical significance of RAS-MAPK pathway mutations in Acute Myeloid Leukemia: Insights from a retrospective cohort

Blood (2025) 146 (Supplement 1): 5185.

https://doi.org/10.1182/blood-2025-5185

Published: 2025

Journal Articles

HOPE (Hematology/Oncology Practical Education)

Lauren Granat, Hetty Carraway, John Molina

Blood (2025) 146 (Supplement 1): 8210.

https://doi.org/10.1182/blood-2025-8210

Published: 2025

Journal Articles

Risk of cardiovascular disease-related mortality in hematologic malignancy patients: A population-level US retrospective cohort study, 1975-2022

Husayn Ladha, Hetty Carraway, Aaron Gerds, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Faiz Anwer, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 4497.

https://doi.org/10.1182/blood-2025-4497

Published: 2025

Journal Articles

Real-time interleukin-6 (IL-6) kinetics predict cytokine release syndrome (CRS) in patients receiving chimeric antigen receptor (CAR) T-cell therapy for Relapsed/Refractory B-cell malignancies

Agrima Mian, Rafaella Ferreira De Araujo Litvin, Jessica Colon-Franco, Sujata Patil, Megan Molnar, Allison Winter, Sandra Mazzoni, Robert Dean, Louis Williams, Aaron Gerds, John Molina, Shahzad Raza, Faiz Anwer, Deepa Jagadeesh, Betty K. Hamilton, Claudio Brunstein, Brian Hill, Paolo Caimi

Blood (2025) 146 (Supplement 1): 2397.

https://doi.org/10.1182/blood-2025-2397

Published: 2025

Journal Articles

Association of socioeconomic indicators with survival in chronic myeloid leukemia: A retrospective analysis

Blood (2025) 146 (Supplement 1): 4636.

https://doi.org/10.1182/blood-2025-4636

Published: 2025

Journal Articles

Major adverse cardiovascular events (MACE) in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: A target trial emulation study

Omer Ashruf, Henyah Dardir, Ankit Patel, Emily Moncher, Nandhini Ravichandran, David Kaelber, Sophia Balderman, Anjali Advani, John Molina, Moaath Mustafa Ali, Aaron Gerds, Hetty Carraway, Faiz Anwer, Abhay Singh, Sudipto Mukherjee, Larry Cripe, Akriti Jain

Blood (2025) 146 (Supplement 1): 4627.

https://doi.org/10.1182/blood-2025-4627

Published: 2025

Journal Articles

Impact of cohesin complex gene mutations on clinical outcomes in Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 4626.

https://doi.org/10.1182/blood-2025-4626

Published: 2025

Journal Articles

TP53 and PPM1D mutations in AML: Distinct frequencies, shared pathway, and adverse prognostic trends

Blood (2025) 146 (Supplement 1): 5168.

https://doi.org/10.1182/blood-2025-5168

Published: 2025

Journal Articles

Clone wars: Evidence of clonal stability in a longitudinal prospective cohort of cancer survivors with serial NGS analysis

Blood (2025) 146 (Supplement 1): 6712.

https://doi.org/10.1182/blood-2025-6712

Published: 2025

Journal Articles

Prognostic impact of mutations in the DNA methylation pathway on clinical outcomes in acute myeloid leukemia: A retrospective cohort study

Blood (2025) 146 (Supplement 1): 5254.

https://doi.org/10.1182/blood-2025-5254

Published: 2025

Journal Articles

Final results of a phase I/II trial of palbociclib and CPX-351 in patients with Acute Myeloid Leukemia

Chana Peysin, Aziz Nazha, Wei Wei, Aaron Gerds, Xiaoying Chen, Hetty Carraway, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Eric Parsons, Jenna Thomas, Bhumika Patel, Jaroslaw Maciejewski, Mikkael Sekeres, Babal Jha, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 3420.

https://doi.org/10.1182/blood-2025-3420

Published: 2025

Journal Articles

Spliceosome mutations in AML: Prevalence, clinical features, and treatment outcomes in a contemporary cohort

Blood (2025) 146 (Supplement 1): 3396.

https://doi.org/10.1182/blood-2025-3396

Published: 2025

Journal Articles

A phase II study of eltrombopag in patients with low-risk MDS and CMML harboring TET2 mutations

Abhay Singh, Akriti Jain, Sophia Balderman, Sujata Patil, Anjali Advani, Moaath Mustafa Ali, John Molina, Taylor Lucas, Tracy Cinalli, Ramandeep Mann, Lucy McCahon, Sudipto Mukherjee, Aaron Gerds, Yogen Saunthararajah, Jaroslaw Maciejewski, Hetty Carraway, Babal Jha, Alex Adjei

Blood (2025) 146 (Supplement 1): 2096.

https://doi.org/10.1182/blood-2025-2096

Published: 2025

Journal Articles

Comparative risk of major adverse cardiovascular events in polycythemia vera patients treated with ruxolitinib, hydroxyurea, or interferon: A real-world, propensity-matched cohort study

Ali Mushtaq, Omer Ashruf, Larry Cripe, Abhay Singh, John Molina, Hetty Carraway, Sudipto Mukherjee, Aaron Gerds, Akriti Jain

Blood (2025) 146 (Supplement 1): 3826.

https://doi.org/10.1182/blood-2025-3826

Published: 2025

Journal Articles

Risk of second primary malignancies and leukemic transformation in patients with Philadelphia chromosome-negative myeloproliferative neoplasms: A population-level US retrospective cohort study

Debolina Pramanik, Yanwen Chen, Shramana Sarkar, Aaron Gerds, Hetty Carraway, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Faiz Anwer, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 3790.

https://doi.org/10.1182/blood-2025-3790

Published: 2025

Journal Articles

Epigenetic dysregulation of the polycomb axis in Acute Myeloid Leukemia: Clinical and prognostic correlates

Blood (2025) 146 (Supplement 1): 7035.

https://doi.org/10.1182/blood-2025-7035

Published: 2025

Journal Articles

Real-world response and toxicity profiles of sequential bispecific antibody therapies in Relapsed/Refractory multiple myeloma

Agrima Mian, Rafaella Ferreira De Araujo Litvin, Kelsey Pandrangi, Kristina Nasr, Sharan Jhaveri, Mikhaila Rice, Joslyn Rudoni, Louis Williams, Christy Samaras, John Molina, Betty K. Hamilton, Shahzad Raza, Faiz Anwer, Jason Valent, Claudio Brunstein, Brian Hill, Paolo Caimi, Sandra Mazzoni

Blood (2025) 146 (Supplement 1): 6376.

https://doi.org/10.1182/blood-2025-6376

Published: 2025

Journal Articles

Survival and risk of second primary malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: A retrospective US population-level analysis

Debolina Pramanik, Yanwen Chen, Shramana Sarkar, Ishan Gupta, Aaron Gerds, Hetty Carraway, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Faiz Anwer, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 3772.

https://doi.org/10.1182/blood-2025-3772

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Outcomes of adolescent and young adult patients with AML treated on adult versus pediatric protocols

Infection risk factors and burden in patients treated with T-cell engaging bispecific antibodies for relapsed B-cell lymphoma and multiple myeloma

Clinical significance of RAS-MAPK pathway mutations in Acute Myeloid Leukemia: Insights from a retrospective cohort

HOPE (Hematology/Oncology Practical Education)

Risk of cardiovascular disease-related mortality in hematologic malignancy patients: A population-level US retrospective cohort study, 1975-2022

Real-time interleukin-6 (IL-6) kinetics predict cytokine release syndrome (CRS) in patients receiving chimeric antigen receptor (CAR) T-cell therapy for Relapsed/Refractory B-cell malignancies

Association of socioeconomic indicators with survival in chronic myeloid leukemia: A retrospective analysis

Major adverse cardiovascular events (MACE) in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: A target trial emulation study

Impact of cohesin complex gene mutations on clinical outcomes in Acute Myeloid Leukemia

TP53 and PPM1D mutations in AML: Distinct frequencies, shared pathway, and adverse prognostic trends

Clone wars: Evidence of clonal stability in a longitudinal prospective cohort of cancer survivors with serial NGS analysis

Prognostic impact of mutations in the DNA methylation pathway on clinical outcomes in acute myeloid leukemia: A retrospective cohort study

Final results of a phase I/II trial of palbociclib and CPX-351 in patients with Acute Myeloid Leukemia

Spliceosome mutations in AML: Prevalence, clinical features, and treatment outcomes in a contemporary cohort

A phase II study of eltrombopag in patients with low-risk MDS and CMML harboring TET2 mutations

Comparative risk of major adverse cardiovascular events in polycythemia vera patients treated with ruxolitinib, hydroxyurea, or interferon: A real-world, propensity-matched cohort study

Risk of second primary malignancies and leukemic transformation in patients with Philadelphia chromosome-negative myeloproliferative neoplasms: A population-level US retrospective cohort study

Epigenetic dysregulation of the polycomb axis in Acute Myeloid Leukemia: Clinical and prognostic correlates

Real-world response and toxicity profiles of sequential bispecific antibody therapies in Relapsed/Refractory multiple myeloma

Survival and risk of second primary malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: A retrospective US population-level analysis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only